Metabolon is a proud sponsor of the Molecular Med Tri-Conference being held in San Francisco, CA from February 11-16, 2018.


You'll find us at Booth #2003 at the Symposia venue, the Hilton San Francisco Union Square, from February 15-16.


Also, please join us for a presentation to learn more about how Precision Metabolomics™ can enhance your R&D efforts.

Precision Metabolomics™ - Current State and Future Plans


Thursday, February 15, 2018

10:00 – 10:30am PST

Hilton Union Square


Presented by Luke Miller, PhD

Vice President, Lab Operations, Metabolon


We will present an overview of Precision Metabolomics, an advanced approach to metabolomics that has the sensitivity and specificity to accurately measure metabolites at a level that makes an n of 1 study in an individual practicable. This approach uses extensively controlled processes to provide data with the smallest degree of variability in the measurement (<5%) to allow precise identification of the maximum possible number of biologically relevant metabolites in a sample. The goal is to comprehensively and reproducibly map metabolism and metabolic change induced by perturbation, such as disease or treatment, with sufficient precision to produce actionable information at the level of the individual.


At Metabolon, we have put this technology into practice, with processes that are tightly regulated through infrastructure controls, documented SOPs, labelled internal standards and proprietary informatics, and the use of a tier one approach to identification of metabolites in each sample. In this presentation, Dr. Miller will discuss the technology that that allows us to carry out n of 1 studies that enable precision medicine, demonstrate the importance of metabolomics alongside genomic studies, and discuss some of our future technology improvements to continue to expand our capabilities.



Hilton Union Square

333 O'Farrell Street

San Francisco, CA  94102